AARDVARK THERAPEUTICS (NASDAQ: AARD) SECURITIES CLASS ACTION: ROSEN, A TOP RANKED LAW FIRM, Encourages Investors with Losses in Excess of $100K to Secure Counsel Before Important October 13 Deadline
NEW YORK, Oct. 7, 2026 /PRNewswire/ -- AARDVARK THERAPEUTICS SECURITIES CLASS ACTION: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Aardvark Therapeutics, Inc. (NASDAQ: AARD): (i) common stock pursuant and/or traceable to the registration statement and...
Covered in this story
What has happened since
- Aardvark Therapeutics Inc is down 21.4% since this was published, 13 days ago.
- TOP Financial Group is down 3.8% since this was published, 13 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $AARD yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Aardvark Therapeutics Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.